TRPV1: A Potential Therapeutic Target in Type 2 Diabetes and Comorbidities?

被引：41

作者：

Gram, Dorte X. ^{[1
]}

Holst, Jens J. ^{[2
]}

Szallasi, Arpad ^{[3
]}

机构：

[1] Pila Pharma, Malmo, Sweden

[2] Univ Copenhagen, Panum Inst, Copenhagen, Denmark

[3] Baptist Med Ctr, Jacksonville, FL USA

来源：

TRENDS IN MOLECULAR MEDICINE | 2017年 / 23卷 / 11期

关键词：

GENE-RELATED PEPTIDE; SENSORY NERVE DESENSITIZATION; SUBSTANCE-P; INSULIN-SECRETION; GLUCOSE-TOLERANCE; PERIPHERAL NEUROPATHY; INFLAMMATORY MARKERS; VANILLOID RECEPTOR-1; CAPSAICIN RECEPTORS; ISLET INFLAMMATION;

D O I：

10.1016/j.molmed.2017.09.005

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

With an estimated 422 million affected patients worldwide in 2016, type 2 diabetes (T2D) has reached pandemic proportions and represents a major unmet medical need. T2D is a polygenic disease with a chronic, low-grade inflammatory component. Second-generation transient receptor potential vanilloid-1 (TRPV1) antagonists are potent anti-inflammatory agents with proven clinical safety. In rodent models of T2D, TRPV1 blockade was shown to halt disease progression and improve glucose metabolism. Thus, we propose that TRPV1 antagonists merit further study as novel therapeutic approaches to potentially treat T2D and its comorbidities.

引用

页码：1002 / 1013

页数：12

共 50 条

[31] Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer
Wojcik, Marzena
Krawczyk, Michal
Wojcik, Pawel
Cypryk, Katarzyna
Wozniak, Lucyna Alicja
CURRENT MEDICINAL CHEMISTRY, 2017, 24 (35) : 3829 - 3850
[32] Botulinum Toxin Type A Reduces Hyperalgesia and TRPV1 Expression in Rats with Neuropathic Pain
Xiao, Lizu
Cheng, Jianguo
Zhuang, Yu
Qu, Wenchun
Muir, Jeffery
Liang, Haowen
Zhang, Deren
PAIN MEDICINE, 2013, 14 (02) : 276 - 286
[33] TRPV1 Properties in Thoracic Dorsal Root Ganglia Neurons are Modulated by Intraperitoneal Capsaicin Administration in the Late Phase of Type-1 Autoimmune Diabetes
Radu, Beatrice Mihaela
Iancu, Adina Daniela
Dumitrescu, Diana Ionela
Flonta, Maria Luisa
Radu, Mihai
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2013, 33 (02) : 187 - 196
[34] Therapeutic Potential of Laminin-Biodritin Microcapsules for Type 1 Diabetes Mellitus
Campanha-Rodrigues, Ana Lucia
Grazioli, Gisella
Oliveira, Talita C.
Campos-Lisboa, Ana Carolina V.
Mares-Guia, Thiago R.
Sogayar, Mari C.
CELL TRANSPLANTATION, 2015, 24 (02) : 247 - 261
[35] The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus
Kootte, R. S.
Vrieze, A.
Holleman, F.
Dallinga-Thie, G. M.
Zoetendal, E. G.
de Vos, W. M.
Groen, A. K.
Hoekstra, J. B. L.
Stroes, E. S.
Nieuwdorp, M.
DIABETES OBESITY & METABOLISM, 2012, 14 (02) : 112 - 120
[36] Anthocyanins: Potential Therapeutic Approaches towards Obesity and Diabetes Mellitus Type 2
Franco-San Sebastian, Denise
Alaniz-Monreal, Samary
Rabadan-Chavez, Griselda
Vazquez-Manjarrez, Natalia
Hernandez-Ortega, Marcela
Gutierrez-Salmean, Gabriela
MOLECULES, 2023, 28 (03):
[37] Transient receptor potential vanilloid subtype 1: A potential therapeutic target for fibrotic diseases
Peng, Guangxin
Tang, Xiaoling
Gui, Yang
Yang, Jing
Ye, Lifang
Wu, Liuyang
Ding, Ya Hui
Wang, Lihong
FRONTIERS IN PHYSIOLOGY, 2022, 13
[38] The transient receptor potential vanilloid 1 (TRPV1) receptor protects against the onset of sepsis after endotoxin
Clark, Natalie
Keeble, Julie
Fernandes, Elizabeth S.
Starr, Anna
Liang, Lihuan
Sugden, David
de Winter, Patricia
Brain, Susan D.
FASEB JOURNAL, 2007, 21 (13) : 3747 - 3755
[39] Role of sensory neurons, neuroimmune pathways, and transient receptor potential vanilloid 1 (TRPV1) channels in a murine model of breast cancer metastasis
Erin, Nuray
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (02) : 307 - 314
[40] Free fatty acid receptor 1 as a novel therapeutic target for type 2 diabetes mellitus-current status
Eleazu, Chinedum
Charles, Ayogu
Eleazu, Kate
Achi, Ngozi
CHEMICO-BIOLOGICAL INTERACTIONS, 2018, 289 : 32 - 39

← 1 2 3 4 5 →